Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Trademark Search
NUGALVIQ
FORMALIZED
on 29 Nov 2024
Last Applicant/ Owned by
Applied Therapeutics, Inc
545 Fifth Avenue, Suite 1400New York, NY 10017
US
Serial Number
2117762 filed on 30th Jun 2021
Correspondent Address
SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO
ONTARIO
CA
M5H3Y2
NUGALVIQ
Trademark usage description
pharmaceutical preparations for treatment of rare orphan diseases; pharmaceutical preparations for treatment of diseases that impact sugar and glucose Read MoreClassification Information
Class [005]
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) and PMM2-congential disorder of glycosylation (PMM2-CDG)
Classification kind code
11
Mark Details
Serial Number
2117762
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 22 on 29th Nov 2024 | Search Recorded |
| Submitted for opposition 20 on 29th Nov 2024 | Examiner's First Report |
| Submitted for opposition 67 on 27th Sep 2024 | Agent Name Changed |
| Submitted for opposition 287 on 06th Jul 2022 | Pre-Assessment Letter Sent |
| Submitted for opposition 30 on 30th Jun 2021 | Filed |
| Submitted for opposition 1 on 30th Jun 2021 | Created |
| Submitted for opposition 31 on 30th Jun 2021 | Formalized |